WithdrawnNot Applicable

Integrated RF and B-mode Deformation Analysis for 4D Stress Echocardiography

Stopped: Study was never started.

0Started 2023-07

Plain-language summary

The specific aim of this clinical trial is to translate the investigators new 4DE (three sptial dimensions pluse time) stress echocardiographic method to patients with coronary artery disease referred for clinically indicated dobutamine stress/rest echo to evaluate the reproducibility of the technique in this clinical setting.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * At least 18 years of age, referred for clinically indicated dobutamine rest/stress TTE * Provide written informed consent to participate in the study * Availability for repease rest/stress TTE within on eweek of clinically indicated study Exclusion Criteria: * Unable to give informed consent * Unstable hemodynamics that would not allow for repease rest/stress dobutamine transthoracic imaging * Recurrent life threatening arrhythmias * Heart rate \>110 BPM * Inadequate windows for transthoracic imagine * Patients that have a narrow-angle glaucoma (contraindication for atropine) * Change in cardiac medications or management including, coronary revascularization beween intial and repeat TTE study.

What they're measuring

Number of Subjects With an Interpretable 4DE Image

Timeframe: After Stress Echocardiography (Approximately 2 hours)

Trial details

NCT IDNCT02327455

SponsorYale University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-09

View on ClinicalTrials.gov More Coronary Artery Disease trials